Alpha Tau Medical Ltd.
DRTS
$2.91
-$0.00010.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -8.44% | -11.40% | -17.70% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 13.03% | 10.82% | 11.03% | |
| Operating Income | -- | -13.03% | -10.82% | -11.03% | |
| Income Before Tax | -- | -21.08% | -79.11% | 13.64% | |
| Income Tax Expenses | -- | -145.76% | -110.26% | -20.00% | |
| Earnings from Continuing Operations | -- | -20.65% | -78.65% | 13.64% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -20.65% | -78.65% | 13.64% | |
| EBIT | -- | -13.03% | -10.82% | -11.03% | |
| EBITDA | -- | -13.22% | -10.96% | -11.21% | |
| EPS Basic | -- | -19.89% | -77.50% | 36.14% | |
| Normalized Basic EPS | -- | -21.32% | -194.89% | -194.89% | |
| EPS Diluted | -- | -19.89% | -77.50% | 36.14% | |
| Normalized Diluted EPS | -- | -21.32% | -194.89% | -194.89% | |
| Average Basic Shares Outstanding | -- | 0.75% | 0.88% | 9.30% | |
| Average Diluted Shares Outstanding | -- | 0.75% | 0.88% | 9.30% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |